ADCT
Price
$4.30
Change
-$0.03 (-0.69%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
536.39M
104 days until earnings call
Intraday BUY SELL Signals
ANAB
Price
$41.65
Change
-$0.51 (-1.21%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
1.17B
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs ANAB

Header iconADCT vs ANAB Comparison
Open Charts ADCT vs ANABBanner chart's image
ADC Therapeutics SA
Price$4.30
Change-$0.03 (-0.69%)
Volume$100
Capitalization536.39M
AnaptysBio
Price$41.65
Change-$0.51 (-1.21%)
Volume$23.69K
Capitalization1.17B
ADCT vs ANAB Comparison Chart in %
ADCT
Daily Signal:
Gain/Loss:
ANAB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADCT vs. ANAB commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and ANAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 28, 2025
Stock price -- (ADCT: $4.33 vs. ANAB: $42.16)
Brand notoriety: ADCT and ANAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 44% vs. ANAB: 93%
Market capitalization -- ADCT: $536.39M vs. ANAB: $1.17B
ADCT [@Biotechnology] is valued at $536.39M. ANAB’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileANAB’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • ANAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 6 TA indicator(s) are bullish while ANAB’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 6 bullish, 3 bearish.
  • ANAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than ANAB.

Price Growth

ADCT (@Biotechnology) experienced а +7.71% price change this week, while ANAB (@Biotechnology) price change was +13.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.81%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +75.56%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

ANAB is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($1.17B) has a higher market cap than ADCT($536M). ANAB YTD gains are higher at: 218.429 vs. ADCT (117.588). ANAB has higher annual earnings (EBITDA): -59.63M vs. ADCT (-115M). ANAB (266M) and ADCT (265M) have equal amount of cash in the bank . ANAB has less debt than ADCT: ANAB (15.1M) vs ADCT (118M). ANAB has higher revenues than ADCT: ANAB (123M) vs ADCT (77.2M).
ADCTANABADCT / ANAB
Capitalization536M1.17B46%
EBITDA-115M-59.63M193%
Gain YTD117.588218.42954%
P/E RatioN/AN/A-
Revenue77.2M123M63%
Total Cash265M266M100%
Total Debt118M15.1M781%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTANAB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
ANAB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJFCX41.340.34
+0.83%
PGIM Jennison Growth C
SAOAX30.810.21
+0.69%
NAA Opportunity A
NGREX10.400.07
+0.68%
Northern Global Real Estate Index
JDERX12.110.06
+0.50%
PGIM Jennison Mid-Cap Growth R
FIJGX58.430.23
+0.40%
Fidelity Advisor Telecommunications Z